REPH — Recro Pharma, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Company fundamentals
| Metric | Cached value |
|---|---|
| Price (USD) | 2.09 |
| Market cap (USD) | 177,424,700 |
| P/E | -7.89 |
| ROE (%) | -22.4 |
| Net profit margin (%) | -15.73 |
| Revenue growth (%) | 4.9 |
| Dividend yield (%) | 0 |
Price last refreshed: .
Prices refreshed every 5 minutes during US market hours. Individual quotes may be older when provider data is missing or a refresh is incomplete. Check each quote's timestamp.
About Recro Pharma, Inc.
Available company fundamentals for REPH in Drug Manufacturers - Specialty & Generic. Values reflect cached source data, not live executable quotes. Valory Formula, when available, is informational analysis, not investment advice.